Mutiple microRNAs are implicated in oral squamous cell carcinoma (OSCC), which is
characterized by a high rate of proliferation and nodal metastasis. Data from the present …

Dysregulation of fibroblast growth factor (FGF) signaling in renal cell carcinoma is now well
understood, and it is becoming increasingly likely that certain tumors become dependent on …

This study aimed to explore the spatio-temporal expression patterns of congenital anomalies
of kidney and urinary tract (CAKUT) candidate genes, Fibroblast Growth Factor Receptor 1 …

Non–clear cell renal cell carcinoma includes several histological variants. Tumor biology
has significant effect on the duration of the disease. Prognosis at formally similar disease …

Alofanib (RPT835) is a novel selective allosteric inhibitor of fibroblast growth factor receptor
2 (FGFR2). We showed previously that alofanib could bind to the extracellular domain of …

Purpose Early data suggest that combining FGFR2 inhibitors with platinum-containing
cytotoxic agents for the treatment of epithelial ovarian cancer may yield increased antitumor …

Background Sweat gland carcinomas are rare cutaneous adnexal malignancies. Aggressive
digital papillary adenocarcinoma (ADPA) represents a very rare subentity, thought to arise …

Long noncoding RNAs (lncRNAs) function as competing endogenous RNAs (ceRNAs).
ceRNA networks may serve important roles in various tumors, as demonstrated by an …

In this work, we utilized a biomimetic approach for targeting KATO (III) tumor cells and 3D
tumoroids. Specifically, the binding interactions of the bioactive short peptide sequences …

Background: There is the evidence of the role of the fibroblast growth factor and its receptors
(FGF/FGFR) signaling pathway in tumorogenesis of renal cell carcinoma (RCC). We …